|
|
|
 |
|
 |
 |
|
|
|
| Trade name |
|
|
|
MEDRx Co., Ltd |
| Establishment |
|
|
|
January, 2002 |
| Head office |
|
|
|
431-7 Nishiyama Higashikagawa-city, Kagawa, Japan 769-2712
TEL: +81-879-23-3071
FAX: +81-879-23-3072
|
| Tokyo office |
|
|
|
Shimazuru Build. 2F, 2-35-7 Hama-cho, Nihonbashi, Chuou-ku, Tokyo, Japan 103-0007
TEL：+81-3-3664-9630
FAX：+81-3-3664-9660
|
| Osaka office |
|
|
|
Nishikawa-Mitsui Build. #403, 1-3-14 Kitahama, Chuo-ku, Osaka-city, Osaka, Japan 541-0041
TEL：+81-6-6208-2412
FAX：+81-6-6208-2413
|
| Shirotori Labo |
|
|
|
1055 Matsubara Higashikagawa-city, Kagawa, JAPAN 769-2702
TEL：+81-879-26-3094
FAX：+81-879-26-0036
|
| IL Pharma Inc. |
|
|
|
One Broadway, 14th Floor
Cambridge, MA USA 02142
TEL: +1-617-475-1546
|
| President & CEO |
|
|
|
Masayoshi Matsumura |
| Capital Fund |
|
|
|
1,622.1 million yen |
|
|
 |
|
 |
|
|
|
|
|
|
|
|
| January, 2002 |
|
|
|
Founded as MEDRx Co., Ltd |
| February, 2004 |
|
|
|
Acquisition of Ethical Pharmaceutical Manufacturer's License |
| December, 2004 |
|
|
|
Raised funds from Japanese venture capitals and corporate investors |
| August, 2005 |
|
|
|
Launch a sales of Iodocoat (R) Ointment 0.9% |
| December, 2006 |
|
|
|
Raised funds from Japanese venture capitals and corporate investors |
| August, 2007 |
|
|
|
Moving of head office |
| October, 2007 |
|
|
|
Launch a sales of Medcaine (R) Oral Jelly 2% |
| October, 2007 |
|
|
|
Established IL Pharma Inc in USA as a subsidiary |
| September, 2009 |
|
|
|
Established a new joint venture company with Kaneka Co. |
|
|
|
|
|
|
|
|
|
|
|
|
Masayoshi Matsumura
President and CEO |
|
|
|
Masayoshi Matsumura graduated from Kyoto Pharmaceutical University and joined the pharmaceutical company, Teikoku Seiyaku Co., Ltd in 1972. He had managed the company as a board member since 1973 and as COO since 1975 until 2000.
He was responsible for research and development of the first generation transdermal poultice (cold and hot hydrophilic patch) and the second generation transdermal poultice (hydrophilic patch including NSAIDs) for the ethical pharmaceutical market. He also took the initiative in forming alliances with pharmaceutical companies involving sales, expansion of business overseas and development of new business. And Teikoku Seiyaku group grew up to current annual sales of 40 billion yen from annual sales of less than 200 million yen in 1972.
He used to be a vice president, Teikoku Seiyaku Co., Ltd, president and CEO, Oｈta Seiyaku Co., Ltd, president and CEO, Teikoku Medix Co., Ltd, president and CEO, Teikoku Kanpo Seiyaku Co., Ltd.
2002- Established MEDRx and became president and CEO, MEDRx Co., Ltd
|
|
Keiko Yamasaki
board member
|
|
|
|
She graduated from Faculty of Agriculture in Kagawa University and joined the pharmaceutical company, Teikoku Seiyaku Co., Ltd in 1981. She worked at R&D department and used to be a board member of Teikoku Pharmacare Co., Ltd. She joined MEDRx Co. Ltd in 2002.
2002- Board Member, MEDRx Co. Ltd
|
|
Hiroshi Akitomo
board member and Tokyo office Manager
|
|
|
|
Hiroshi Akitomo received Master of Agriculture at Kagawa University. He joined the pharmaceutical company, Teikoku Seiyaku Co., Ltd in 1987 and worked at R & D department. He joined MEDRx. Co. Ltd in 2002.
2005- Board Member, MEDRx Co. Ltd
|
|
Yonehiro Matsumura
board member
|
|
|
|
Yonehiro Matsumura received Master of Agriculture at Tokyo University and joined as a business consultant in Corporate Directions, Inc in 1995. He joined MEDRx Co. Ltd in 2003 as a board member.
2003- Board Member, MEDRx Co. Ltd
|
|
Jun-ichi Tamura
board member and Osaka office Manager
|
|
|
|
Jun-ichi Tamura received Master of Pharmacy at Tohoku Pharmaceutical University. He joined the pharmaceutical company, Dainippon Pharma Co., Ltd in 1968 and used to be the position of operating officer. He joined MEDRx. Co. Ltd in 2005.
2007- Board Member, MEDRx Co. Ltd
|
|
|
|
|
|
|
